EU to consider medtech incentives to address rare diseases
This article was originally published in SRA
Executive Summary
The European Commission plans to assess whether legislative measures are needed to encourage the development of medical technology for rare diseases. In a communication outlining its strategy for improving the diagnosis and treatment of rare diseases, the commission notes that, unlike in the pharmaceutical area, there is currently no policy for medical devices in this field1.